Skip to content

Comparing mixture of local anaesthetic 0.5 % bupivacaine with fentanyl versus mixture of local anaesthetic ropivacaine 0.75% with fentanyl during operations in lower limb and lower abdomen

Comparison of intrathecal 0.5% hyperbaric bupivacaine plus fentanyl with 0.75% hyperbaric ropivacaine plus fentanyl in lower limb and lower abdominal surgeries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046588
Enrollment
60
Registered
2022-10-18
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Intrathecal 0.75% hyperbaric Ropivacaine plus Fentanyl: Dose:3 ml of ropivacaine 7.5 mg/ml containing dextrose 80 mg/ml with fentanyl 25 mcg, Frequency:once, Route:Intrathecal, Duration

Sponsors

ESIC Medical College and PGIMSR KK Nagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patient with written informed consent 2 ASA physical status of I and II 3 Patient Posted for lower limb and lower abdominal surgeries 4 Age groups 18- 60 years

Exclusion criteria

Exclusion criteria: 1 Patient refusal 2 Known allergy to local anaesthetics 3 Gross spinal deformities 4 Pregnancy and Lactating females 5 Contraindications to regional anaesthesia (bleeding diathesis, use of any anti-coagulants, infection at the site of injection)

Design outcomes

Primary

MeasureTime frame
Comparison of the duration of motor block between the two drugsTimepoint: At 2 hours, 3 hours,4 hours,5 hours,6 hours

Secondary

MeasureTime frame
Duration of sensory blockTimepoint: Every 15 min;Hemodynamic parametersTimepoint: Every 15min;Time of motor blockTimepoint: Every 15 min;Time to onset of sensory blockTimepoint: Every 1 min

Countries

India

Contacts

Public ContactDr Radhika K

ESIC Medical College and PGIMSR KK Nagar

radhikamurali0095@gmail.com9840170887

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026